Endovascular Aneurysm Repair (EVAR) Market Size and Share Analysis - Growth Trends and Forecasts (2026-2033)

Market Size and Trends

The Endovascular Aneurysm Repair (EVAR) market is estimated to be valued at USD 3.25 billion in 2026 and is expected to reach USD 5.87 billion by 2033, growing at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033. This significant growth reflects increasing prevalence of aortic aneurysms, advancements in minimally invasive surgical techniques, and expanding adoption of EVAR devices across healthcare facilities worldwide.

Market trends indicate a shift towards innovative, less invasive treatment options, driving demand for EVAR procedures. Enhanced imaging technologies and development of next-generation stent grafts are improving patient outcomes and procedural efficiency. Furthermore, rising awareness about the benefits of EVAR over traditional open surgery and increasing investment in healthcare infrastructure, particularly in emerging markets, are fueling the market's robust expansion.

Segmental Analysis:

By Device Type: Dominance of Standard Stent Grafts Driven by Versatility and Established Clinical Outcomes

In terms of By Device Type, Standard Stent Grafts contribute the highest share of the Endovascular Aneurysm Repair (EVAR) market owing to their widespread clinical adoption and proven safety profile. These devices have been the cornerstone of EVAR procedures for a considerable time, offering a reliable and minimally invasive alternative to open aneurysm repair surgeries. The preference for standard stent grafts is deeply rooted in their versatility to treat a broad spectrum of aneurysms, particularly abdominal aortic aneurysms, without the need for complex customization. Their established manufacturing processes and regulatory approvals have further bolstered healthcare providers' confidence in their efficacy, translating into frequent utilization in various healthcare settings.

Standard stent grafts also benefit from ongoing technological refinements aimed at improving deliverability and conformability to the patient's vascular anatomy. This ensures lower procedural times and reduced complication rates, factors that are crucial for both surgeons and patients. The relative cost-effectiveness of these devices in comparison to more complex alternatives, such as fenestrated or branched stent grafts, adds to their appeal among providers working under budget constraints or in regions with limited access to highly specialized equipment. Additionally, clinical guidelines often prioritize these devices for typical aneurysm cases, reinforcing their dominant position in the device segment. Collectively, these factors contribute to the sustained growth and high market share of standard stent grafts in the EVAR segment.

By Aneurysm Location: Abdominal Aortic Aneurysm (AAA) Leads Owing to High Prevalence and Screening Initiatives

By Aneurysm Location, Abdominal Aortic Aneurysm (AAA) accounts for the largest market share within the EVAR landscape. The prominence of AAA in the market is primarily driven by its higher prevalence compared to other aneurysm types, making it a critical focus area for endovascular treatment. AAA typically arises due to age-related degeneration of the abdominal aorta, with risk factors such as smoking, hypertension, and atherosclerosis contributing to its incidence. These demographic and clinical factors have led to widespread awareness and targeted screening programs designed to detect aneurysms before rupture, fueling an increasing number of elective repair procedures.

The preference for EVAR in AAA treatment is also linked to patient outcomes. Endovascular repair has demonstrated fewer complications, shorter hospital stays, and faster recovery times compared to open surgery, making it the standard of care in many clinical guidelines worldwide. This advantage is especially relevant given the demographic profile of AAA patients, who tend to be older and may have multiple co-morbidities that increase the risks associated with invasive surgery. Advances in imaging and device delivery systems have similarly enhanced the feasibility of EVAR for AAA, even in anatomically challenging cases, expanding the eligible patient population. These combined factors—high AAA incidence, improved detection, and superior procedural benefits—continue to drive this segment's leading position in the EVAR market.

By End User: Hospitals Lead Market Share Due to Comprehensive Infrastructure and Multidisciplinary Expertise

By End User, hospitals dominate the Endovascular Aneurysm Repair market owing to their superior infrastructure and multidisciplinary clinical expertise. Hospitals typically house advanced imaging technologies, hybrid operating rooms, and provide access to specialized vascular surgeons, interventional radiologists, and anesthesiologists essential for the successful planning and execution of EVAR procedures. Such a comprehensive environment enables hospitals to manage complex cases and potential perioperative complications more effectively than other end users, including ambulatory surgical centers or specialty clinics.

Hospitals also benefit from established patient referral networks, enabling a steady inflow of aneurysm cases suitable for endovascular repair, which further fuels demand. Their ability to provide preoperative assessments, intraoperative monitoring, and postoperative intensive care consolidates their role as the preferred end-user segment for EVAR procedures. Additionally, hospitals are better positioned to invest in training programs and cutting-edge technologies necessary to keep pace with the evolving landscape of endovascular interventions. These factors collectively ensure that hospitals remain the primary healthcare settings where EVAR procedures are performed, maintaining their leadership in terms of market share and procedural volume.

Regional Insights:

Dominating Region: North America

In North America, the dominance in the Endovascular Aneurysm Repair (EVAR) market is primarily driven by a well-established healthcare infrastructure, high adoption of advanced medical technologies, and strong presence of leading medical device companies. The region benefits from supportive government policies such as favorable reimbursement frameworks and extensive funding for cardiovascular research, which encourages innovation and adoption of minimally invasive techniques like EVAR. Furthermore, North America houses headquarters and major R&D centers of notable companies including Medtronic, Gore & Associates, and Boston Scientific, which continuously invest in developing next-generation devices to improve patient outcomes. Robust healthcare awareness and a large patient population with prevalent vascular conditions also fuel demand for EVAR procedures.

Fastest-Growing Region: Asia Pacific

Meanwhile, the Asia Pacific exhibits the fastest growth in the EVAR market, propelled by increasing healthcare expenditure, rising prevalence of lifestyle-related vascular diseases, and expanding access to advanced healthcare facilities in emerging economies such as China and India. Government initiatives aimed at improving healthcare infrastructure and promoting medical tourism have substantially enhanced market penetration. In addition, growing collaborations between local manufacturers and multinational corporations facilitate technology transfer and device availability at competitive pricing, accelerating market expansion. Companies like Terumo Corporation and W. L. Gore & Associates have been actively increasing their footprint in this region through strategic partnerships and localized production, helping to meet the increasing procedural volumes.

Endovascular Aneurysm Repair (EVAR) Market Outlook for Key Countries

United States

The United States' EVAR market benefits from a mature healthcare ecosystem supported by comprehensive insurance coverage and Medicare reimbursement policies, which facilitate patient access to advanced vascular interventions. Key players such as Medtronic and Gore have a strong commercial presence here, offering a wide range of innovative stent graft systems. Continuous clinical research and surgeon training programs supported by these companies help maintain the country's leadership position in EVAR technology and procedural outcomes.

Germany

Germany's market reflects strong government investment in healthcare infrastructure, combined with a well-organized vascular surgery network. The country's regulation favors the swift approval and adoption of cutting-edge EVAR devices. Major companies like W. L. Gore & Associates and Terumo have established distribution centers and partnerships with local hospitals, ensuring steady supply and tailored support for clinicians. These factors contribute to the country's robust utilization of EVAR in treating abdominal and thoracic aortic aneurysms.

China

China is a key driver of EVAR market growth in the Asia Pacific due to substantial government initiatives to expand healthcare access and improve cardiovascular disease management. Increased hospital capacities and growing awareness among healthcare providers and patients lead to higher demand for minimally invasive aneurysm repair techniques. Regional players, alongside global entities such as Medtronic, actively engage in clinical trials and education programs to bolster EVAR adoption. Efforts to streamline device approvals and bring down costs are also notable trends shaping the market landscape.

Japan

Japan continues to lead in technological advancement and clinical research related to EVAR. The country's aging population creates a significant need for effective aneurysm treatments, while the healthcare system ensures broad coverage for such interventions. Companies like Terumo Corporation are at the forefront here, innovating devices suited to the specific anatomical profiles and clinical needs of Japanese patients. Collaboration with research institutions further strengthens Japan's prominent role in refining EVAR techniques.

India

India's EVAR market is expanding with increasing healthcare investments and growing awareness of minimally invasive surgical options. The government's push to upgrade healthcare infrastructure, particularly in tier-2 and tier-3 cities, enables wider access to these procedures. Multinational players such as Medtronic and Boston Scientific are partnering with local hospitals for training and supply chain enhancements, while domestic companies are gradually entering the ecosystem with cost-effective solutions. This blend of factors drives increasing adoption of EVAR procedures across the country.

Market Report Scope

Market Segmentation

Device Type Insights (Revenue, USD, 2021 - 2033)

• Standard Stent Grafts
• Fenestrated Stent Grafts
• Branched Stent Grafts
• Chimney and Snorkel Devices
• Others

Aneurysm Location Insights (Revenue, USD, 2021 - 2033)

• Abdominal Aortic Aneurysm (AAA)
• Thoracic Aortic Aneurysm (TAA)
• Thoracoabdominal Aortic Aneurysm
• Others

End User Insights (Revenue, USD, 2021 - 2033)

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Regional Insights (Revenue, USD, 2021 - 2033)

• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa

Key Players Insights

• Medtronic
• Gore Medical
• Abbott Laboratories
• Terumo Corporation
• C.R. Bard (a BD company)
• Cook Medical
• W.L. Gore & Associates
• Philips Healthcare
• Boston Scientific
• JOTEC GmbH
• Endologix, Inc.
• Lombard Medical
• Endospan Ltd.
• MicroPort Scientific Corporation
• Surmodics, Inc.
• Vascutek (Terumo Group)
• Ev3 (Medtronic subsidiary)
• Bolton Medical
• Bentley InnoMed GmbH
• Zeus Industrial Products